Leadership

Rachel Collins Clarke serves as Chief Legal Officer and General Counsel at Minaris Advanced Therapies, bringing extensive legal expertise in the biotechnology sector with a focus on cell and gene therapy. She leads the global legal function to enable the delivery of transformative therapies for patients worldwide.

Ms. Collins Clarke’s career includes senior legal positions at Adaptimmune and Spark Therapeutics, where she advised on commercialization, clinical development and compliance. She previously served as a litigation partner at Cozen O’Connor, as an Assistant District Attorney in Philadelphia and as an associate at Morgan Lewis & Bockius.

Ms. Collins Clarke earned her law degree from Georgetown University Law Center and her Bachelor of Arts from the College of William and Mary.

Dr. Ilya Koltover serves as Chief Transformation Officer at Minaris Advanced Therapies, bringing extensive experience in commercial leadership within the life sciences industry. He combines expertise in strategy, operations and technology to drive enterprise-wide transformation initiatives that align with the company’s strategic vision and long-term goals.

Dr. Koltover’s career includes senior leadership positions at Solvias, where he served as Chief Commercial Officer, and at MilliporeSigma and Merck Life Science, where he directed global strategy, partnerships and commercial operations. Earlier roles include leadership in the BioReliance testing services business and commercial strategy positions across multiple life science markets.

Dr. Koltover earned his Ph.D. in Physics from the University of California, Santa Barbara and M.S. in Physics from the University of Pennsylvania.

Dr. Luciana Mansolelli serves as our Chief Quality Officer at Minaris Advanced Therapies, bringing over 29 years of global leadership experience in quality, development and manufacturing for advanced therapies, including biologics, medical devices and cutting-edge cell and gene therapies. She has a proven track record of building robust quality systems, driving operational excellence and guiding teams through complex regulatory landscapes. She has extensive experience working with global health authorities and non-governmental bodies on drug development, manufacturing and commercial compliance, as well as legal frameworks across multiple GxP disciplines and products. Dr. Mansolelli leads our global quality strategy, ensuring the highest standards are met across all programs and sites.

Dr. Mansolelli’s career includes global senior leadership positions at Johnson & Johnson Innovative Medicine and Novartis. Earlier in her career, she served as Director of QA for Novartis, leading R&D quality and compliance at Eurofarma and Hexal do Brasil. She began her career as a production supervisor at Boehringer Ingelheim.

Dr. Mansolelli holds a Doctor of Pharmacy from Universidade Estadual de Maringá and an MBA from Fundação Getulio Vargas.

Prakash Manwani serves as Chief Information Officer at Minaris Advanced Therapies, bringing over 20 years of experience in information technology systems across highly regulated industries. He leads the organization’s global IT strategy, driving secure, scalable and innovative technology solutions that support business growth and compliance. Mr. Manwani is responsible for safeguarding the company’s infrastructure, developing secure system architectures and overseeing the design and execution of software implementations, particularly for ERP, MES, QMS, LIMS and other business-critical integrations. With a strong focus on GxP-compliant platforms, his leadership ensures that we maintain robust, FDA-compliant systems to support the delivery of transformative cell and gene therapies worldwide.

Since joining Minaris in 2021, Mr. Manwani has advanced from Head of IT Americas to Global Head of IT and Chief Digital Officer and now CIO. Earlier in his career, he held senior IT leadership roles at Catalent Pharma Solutions, where he directed enterprise architecture, ERP delivery and M&A integrations. And at Accenture, where he led ERP, data integration and BI programs.

Mr. Manwani holds a certificate in the Executive Leadership Program from Cornell University. He has completed the AI and Machine Learning program for executives at the University of Texas, McCombs School of Business. Mr. Manwani has an educational background in Digital Electronics and Computer Systems Management.

Darwin Richardson serves as Chief Operating Officer at Minaris Advanced Therapies, bringing over 25 years of leadership in the biopharmaceutical industry. He oversees end-to-end international operations, including manufacturing, supply chain management, site performance and operational efficiency. He effectively scales our infrastructure to meet growing client demand, ensuring delivery of high-quality therapies and driving cross-functional collaboration to meet strategic business goals. Mr. Richardson’s leadership strengthens our operational agility, fosters innovation and advances our mission to transform patients’ lives through cell and gene therapies.

Mr. Richardson’s career includes serving as Chief Executive Officer of Benuvia Operations, Vice President of Operations and General Manager at Kindeva Drug Delivery and Senior Vice President of Operations and Site Head at Ajinomoto Bio-Pharma Services. Earlier in his career, he held senior quality and regulatory roles at Ajinomoto, BPL Plasma and Baxter, leading complex global operations across compliance, manufacturing and technical functions.

Mr. Richardson holds a Bachelor of Arts in Biology and a minor in Chemistry from CSU Fullerton and an MBA from the University of La Verne.